Essetifin SPA 13D/13G Filings for Fennec Pharmaceuticals Inc. (FENC)

Essetifin SPA 13D and 13G filings for Fennec Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-05-04
5:22 pm
Purchase
2020-04-3013DFennec Pharmaceuticals Inc.
FENC
Essetifin SPA3,993,694
16.200%
768,000increase
(+23.81%)
Filing